Stock Events

LegoChem Biosciences 

₩56,100
2
+₩0+0% Today

Statistics

Day High
56,600
Day Low
53,000
52W High
67,100
52W Low
31,200
Volume
1,232,122
Avg. Volume
980,924
Mkt Cap
403.31B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

21MarExpected
Q1 2022
Q2 2022
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Next
-350.76
-278.75
-206.75
-134.74
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 141080.KQ. It's not an investment recommendation.

About

LegoChem Biosciences, Inc. a biopharmaceutical company, focuses on the development of novel therapeutics utilizing its proprietary LegoChemistry medicinal drug discovery technology and antibody-drug conjugate platform (ADC). It engages in the research and development of ADC, anti-biotic, anti-coagulant, and anti-cancer therapeutics. The company offers its products in the forms of tablets and capsules. It has a research collaboration and license agreement with Iksuda Therapeutics for the development of antibody-drug conjugates in oncology. The company was founded in 2006 and is headquartered in Daejeon, South Korea.
Show more...
CEO
Mr. Yong-Zu Kim
Country
KR
ISIN
KR7141080002

Listings